FOGSI Focus: Adolescent Intervention for Future Reproductive Health Alok Sharma, Rohan Palshetkar, Nandita Palshetkar, Girish Mane
INDEX
Page numbers followed by f refer to figure, fc refer to flowchart, and t refer to table.
A
Abdominal pain, symptoms of 12
Abdomino-pelvic pain, chronic 17
Abnormal uterine 36
bleeding 4, 37, 40, 61
Abortion 42, 43
unsafe 2, 44, 64
Absolute uterine factors 1
Abstinence 61
Acne 36
Acquired anatomical abnormalities 1
Acquired immunodeficiency syndrome 54, 71, 74
Acute bleeding, management of 37
Acyclovir 57
Adenomas 12
Adolescent friendly health services 73
Adolescent health 65
programs 46
Adolescent pregnancy 44, 49
Adolescent reproductive program 2
Adolescent responsive quality healthcare 2
Adolescent-friendly health clinics 74
Adult endometriosis 32, 33
phenotype of 33t
Affect future fertility 39
Age-related fecundity decline 1
Alcohol and drugs 75
Alkylating agents 23
Alpha-fetoprotein 24
Alpha-hydroxylase deficiency 1, 12
Alpha-reductase deficiency 12
Amenorrhea 11
causes of primary 11, 13t, 14t
evaluation of primary 12, 14fc
primary 11, 12, 13, 15
Ampicillin 58
Anal sex 70
Androgen insensitivity syndrome 1, 12, 15
Androstenedione 3
Anemia 15, 48
causes of 48
global burden 48
management of 51, 51t
mild 51
moderate 51
presentation of 49
prevention of 49, 50fc
severe 51
signs and symptoms of 49
treatment of 50
Anogenital warts 2
Anomalies affecting uterus 16
Anorchia 1
Anorectal malformations 1
Anorexia nervosa 12, 15
Antepartum hemorrhage 60
Antiandrogens 72
Antifibrinolytics 39
Anti-müllerian hormone 3
Anxiety 2
Arcuate uterus 16, 16f
Aromatase deficiency 1, 12
Artificial ovary 26
Asherman's syndrome 1
Autoimmune ovarian insufficiency 2
Azithromycin 57
B
Bacterial vaginosis 54, 57
Balanced diet 49
Barrier contraception 61
Benzathine penicillin G 58
Bichloroacetic acid 57
Bicornuate uterus 16, 17f
Bilateral cryptorchidism 1
Blood pressure 3
Body mass index 3
Bone age, tests for 3
Borderline ovarian tumors 24
Boredom 69
BRCA mutation 25
Breast
absent 13
development 3
present 13
Breastfeeding difficulties 45
Bruising, history of 37
C
Calymmatobacterium granulomatis 55
Cancer
adolescents with 5
diagnosis 22
Carcinosarcomas 25
Cardiac disease, end-stage 2
Cefotetan 58
Ceftriaxone 57, 58
Central nervous system 13
Cerebral palsy 1
Cervical
atresia 1
inflammation 55
Cervicitis 57
Chancroid 54, 55
Chemotherapy 23
Child friendly procedures 67
Children from Sexual Offences Act, protection of 60, 66
Chlamydia 2, 37, 54
infection 54, 57
trachomatis 54
Clindamycin 57
Combined oral contraceptive pill 33, 38, 61
Community education 45
Complete blood count 51
Congenital adrenal hyperplasia 1
adult-onset 12
Congenital anomalies 16
Congenital central nervous system defects 1
Congenital lipoid adrenal hyperplasia 12
Congestive cardiac failure 49
Contraception 45, 60, 62
injectable 62, 72
Contraceptives
choice of 72
long-acting reversible 61
Craniopharyngioma 2, 12
Cryotherapy 57
Cushing's disease 12
Cushing's syndrome 2
Cyclic hormone thermotherapy 35
Cyproterone acetate 72
Cystic fibrosis 1
Cytomegalovirus 54
D
Danazol 33
Dating violence 2
Davydov procedure 21
Deep vein thrombosis 38
Dehydroepiandrosterone sulfate 3, 13, 38
Delivery and postpartum 45
Deoxyribonucleic acid 23
Depression 2, 74
Desogestrel 72
Diabetes
mellitus 2
screening for 3
Diarrheal diseases 74
Down's syndrome 1
Doxycycline 57, 58
Drospirenone 72
E
Eating disorders 2
Embryo cryopreservation 22
Emergency contraception 61, 62
Emergency medical care 68
Empty sella 2
turcica 12
Endocrine disrupting chemicals 2
Endocrinological disorders 15
Endometriosis 1, 5, 31f
classification of 34f
pathophysiology of 32f
Enzyme deficiencies 12, 15
Epididymitis 57
Epithelial ovarian cancer 23
Epithelial tumors 25
Erythrocyte sedimentation rate 3
Erythromycin 57
ethylsuccinate 57
Ethinyl estradiol 38
Ethynodiol diacetate 72
Eugonadotropic eugonadism 12, 15
European Society for Medical Oncology 25
European Society of Human Reproduction and Embryology 26
F
False complaint 67
Famciclovir 57
Female intersex 12
Feminine sprays 2
Fertility awareness method 62
Fertility preservation 26fc
facilities 2
Fertility-sparing
methods 22
strategies 25fc
surgery 23, 25
Fertiprotective agents 23, 26
Fetal growth restriction 17
Fibroids 1, 28
Folic acid supplementation 50
Follicle-stimulating hormone 1, 11, 12, 14
Forbes-Albright syndrome 12
Fragile-X permutation 1
Frasier syndrome 14
G
Galactosemia 1, 12
Genetic disorders 12
Genital herpes 55
simplex 57
Genital mutilation 1
Genital tract examination 3
Genital trauma and mutilation 2
Genital tuberculosis 2
Genital warts 55, 57
Germ cell
damage 26
tumors 2, 22, 23
Gonadal dysgenesis 1, 11, 13, 14
Gonadoblastoma 14
Gonadotoxic chemotherapy 2
Gonadotropin levels, classification on 11
Gonadotropin-releasing hormone 13, 14, 23, 26, 35
agonists 33
deficiency 1, 12
receptor mutation 12
Gonadotropin-resistant ovary syndrome 12
Gonococcal infections 57
Gonorrhea 53, 54
prevalence of 54
Granuloma inguinale 54, 55
Gynecological cancers 22
H
Haemophilus ducreyi 55
Health concern 43
Hematocolpos 20
Hematometra 20
Hematosalpinx 20
Hemivagina 17
Hemoglobin 38, 48
Hemogram 3
Hepatitis 54
Herpes simplex 54
Hirsutism 36
signs of 3
Hookworm
prevention of 50
treatment of 50
Hormonal medical therapy 39
Human chorionic gonadotropin 38
Human immunodeficiency virus 43, 54, 60, 68, 69, 74
Human papillomavirus 53, 58
infection 2, 54, 55
Human rights, universal declaration of 64
Hymen, anomalies of 18
Hyperandrogenemia 4
Hypergonadotropic hypogonadism 11, 13
Hypergonadotropic states 14
Hyperprolactinemia 2, 15
Hyperthyroidism 2
Hypogonadotropic hypogonadism 2, 15
Hypogonadotropic states 14
Hypopituitarism 1
Hypothalamic dysfunction 36
Hypothalamic hypogonadism 12
Hypothyroidism 2
Hysterectomized women 26
Hysteroscopic metroplasty 16
I
Imiquimod 57
Imperforate hymen 1, 12, 15, 18, 19f
In vitro ovarian follicle
growth 26
maturation 26
Infection 2, 43
Infertility 43
Inguinal canal, examination of 3
Insulin-like growth factor-1 13
International Conference on Population and Development Programme of Action 64
International Federation of Gynecology and Obstetrics 23
Interpersonal violence 74
Intrauterine
balloon 39
contraceptive device 62, 72
device 70, 71
system 62
Ipsilateral renal agenesis 17
Iron
deficiency anemia 48, 50
requirement, increased 48
supplementation 49
Ivermectin 57, 58
J
Juvenile Justice Act 66
Juvenile police unit 60
K
Kallmann's syndrome 1, 12, 15
Kidney function test 3
Klinefelter's syndrome 1
L
Leiomyomas, etiology of 28
Leptin deficiency 2
Levofloxacin 57
Levonorgestrel 72
intrauterine system 62
Lichen planus 2
Lichen sclerosis 2
Liver
disease, end-stage 2
function test 3
Local irritants, use of 2
Lung disease, end-stage 2
Luteinizing hormone 1, 13, 14, 23
Lymphadenopathy 3
Lymphoblastic leukemia, acute 2
Lymphogranuloma venereum 54, 55, 57
M
Maintenance therapy 40
Malaria 2
parasite testing 51
Malnutrition 12, 15, 73
Mayer-Rokitansky-Küster-Hauser syndrome 1, 12, 15, 20, 20f
Mcindoe
procedure 15
vaginoplasty 20
Medical Termination of Pregnancy Act 68
Medroxyprogesterone acetate 13, 62
Menses, normal and abnormal 36
Menstrual abnormalities 36, 40
Menstrual bleeding 36
pathophysiology of 11
Menstrual hygiene 2, 65
Mental and psychological state 2
Mental health 74
disorders 74
Metabolic and endocrinological problems 1
Metronidazole 57, 58
Mixed connective tissue disease 2
Mosaicism 14
Mosaics 11
Mucopurulent cervicitis 55
Müllerian agenesis 13, 15, 20
diagnosis of 4
Müllerian anomalies 1, 4, 15
Müllerian development
absence of 12
normal 12
Müllerian ducts 19
Mullerian dysgenesis 1
Müllerian tumors 25
Multiple partners 70
Mumps 2
Myeloid leukemia, acute 2
Myxedema 49
N
National Commission for Protection of Children's Rights 66
Neisseria gonorrhoeae 4, 55
Neoplasia 2
Neuroblastoma 2
Nondysgerminomatous tumors 24
Nongonococcal urethritis 55, 57
Non-Hodgkin lymphoma 2
Nonobstructed cervix 17
Nonpharmacological management 39
Nonsteroidal anti-inflammatory drugs 33, 35, 38
Norethindrone 72
Norgestimate, third-generation 72
Norgestrel, second-generation 72
Nutrition and micronutrient deficiencies 75
O
Obesity 1, 36, 75
Obstetric complications 43
Ofloxacin 57
Oocyte
cryopreservation 22
immature 22
Oophoropexy 23
Oral contraceptive 39, 70, 72
Ovarian cancer 22, 25
Ovarian cryopreservation 22
Ovarian cysts 5
Ovarian deficiency, primary 1
Ovarian failure
premature 2
prevention of chemotherapy-associated 23
Ovarian germ cell tumors, malignant 23
Ovarian hyperstimulation, controlled 22
Ovarian reserve, predicting 23
Ovarian teratoma, immature 24
Ovarian transposition 23
Ovarian tumors 2, 22, 23
Ovulatory dysfunction 36
P
Pediculosis pubis 57
Peer pressure 69
Pelvic examination 13
Pelvic inflammatory disease 54, 55, 58, 60
chronic 2
Pelvic irradiation 2
Pelvic pain, chronic 43
Perineal wash 2
Periodic abstinence method 62
Peripheral blood smear, examination of 51
Permethrin 57, 58
Physical activity 75
Pineal gland tumors 12
Piperonyl butoxide 57
Pituitary adenoma 2
Pituitary hypoplasia 12
Platelet count 3
Podofilox 57
Polycystic ovary syndrome 1, 4, 12, 38, 61
Poor perineal hygiene 2
Poor socioeconomic status 2
Postabortal sepsis 2
Prader orchidometer 3
Prader-Willi's syndrome 2
Pregnancy
hypertensive disorders of 60
prevention of 70
unwanted 64, 69, 70
Premarital sex 69
Premature deliveries 60
Progestins 33
Prolactinomas 12
Prostaglandin synthesis inhibitors 39
Pseudohypoparathyroidism 2
Psychological stress 2
Puberty 53
completion of 36
Pulmonary embolism 38
Pure dysgerminoma 24
Pure gonadal dysgenesis 11, 14
Pyrethrins 57
R
Radical surgery 25
Radiotherapy 23
Receptor and enzyme defects 1
Renal disease 49
end-stage 2
Reproductive age, women of 26fc
Reproductive tract anomalies 4
Respiratory illness 49
Rheumatoid arthritis 2
S
Salpingectomy 25
Savage syndrome 12
Scabies 54, 58
Septate uterus 16, 16f
Serum
alpha-fetoprotein 24
anti-müllerian hormone 23
estradiol 3
thyroid-stimulating hormone 13
Sex
and drugs 70
chromosomes
abnormal 11, 13
normal 11
cord stromal tumors, malignant 24
paying for 70
safe 69
unprotected 69, 70
unsafe 69, 70
Sexual abuse 44
Sexual activity, unprotected 69
Sexual and reproductive health 64
Sexual attraction 69
Sexual characters, development of 12
Sexual health 71
program 2
thieves of 1
Sexual history 37
Sexuality 2
education 7072
Sexually transmitted
diseases 4, 53, 60, 68
infection 2, 44, 53, 55, 56, 60, 64, 6971
Sheehan's syndrome 2
Sigmoid vaginoplasty 21
Simmonds disease 12
Social and media pressure 69
Soft tissue 2
Soil transmitted helminths 50
Sphingosine-1-phosphate 26
Spina bifida 1
Spinal injuries 1
Spironolactone derivatives 72
Spontaneous abortion 17
risk for 16
State Commission for Protection of Children's Right 66
Steroid-dependent nephrotic syndrome 2
Stress 12
Subseptate uterus 16
Substance abuse 69
Suicide 74
Sulbactam 58
Swyer's syndrome 1, 11, 14
Syphilis 54, 55, 58
prevalence of 55
T
Teenage pregnancies 42, 60
management of 45
Testicular regression 1
Testicular tumors 2
Tetanus 43
Thyroid
disease 12
function tests 3
stimulating hormone 13, 14
Thyromegaly 3
Tinidazole 57, 58
Tranexamic acid 39
Transgender 2
Transverse vaginal septum 1, 12, 15, 19
types of 19f
Treponema pallidum 55
Trichloroacetic acid 57
Trichomonas vaginalis 55
Trichomoniasis 54, 58
True intersex 12
Tumor 2
marker 3
Turner's syndrome 1, 11, 13
U
Undernutrition 75
Unhygienic conditions 43
Unicornuate uterus 17, 18f
Urethral discharge, abnormal 55
Urethral inflammation 55
Urological tract examination 3
Uterine artery embolization 29
Uterine cavity 18f
Uterine evacuation 40
Uterine fibroid 28, 29
pathophysiology 29f
Uterine leiomyomas 28
Uterine leiomyomata 28f
Uterine rupture 18
Uterus 43
and vagina, congenital absence of 1
didelphys 17, 17f, 19f
present 13
transplantation 26
V
Vagina, anomalies of 19
Vaginal agenesis 20
diagnosis of 21
differential diagnosis of 20
Vaginoplasty 15
Valacyclovir 57
Vasculitis 2
Vecchietti procedure 21
Violence 74
Virilisation, signs of 3
Vision 3
Visual examination 13
Visual field 3
Vitamin A 43
von Willebrand disease 3
Vulvovaginitis 2
W
Weight loss 12
Williams surgery 15
Williams vulvovaginoplasty 21
X
X chromosome, abnormal 11
Y
Y chromosome 1
Yolk sac tumors 24
×
Chapter Notes

Save Clear


Thieves of Sexual Health, Future Fertility and Reproductive Outcomes in AdolescentsCHAPTER 1

Roza Olayi,
Rajorhia Anita
 
INTRODUCTION
Adolescence is a challenging period in life of an individual and envisages development of new relationships and behaviors that persist throughout life. As per WHO, the world now has more young than past and adolescents are one-sixth of the world's population and make around 42% of the young population worldwide. The clinicians attending to these adolescents face unique challenge, while dealing with this age group, due to their varied and complex physical, psychological, social, gynecological and sexual health concerns.
The concern for future fertility and sexual health may be paramount in this age group. The clinicians need to be well versed with their concerns and must be trained enough to counsel about these. There are many factors which may have a large impact on future fertility and sexual health of adolescent age group and require timely interventions to prevent future permanent implications of these conditions.
The various factors which may act as stealers or thieves of future fertility and sexual health of adolescents are as follows; some conditions may fall in the categories of more than one class.1-6,10-12
  • Genetic:
    • Kallmann's syndrome:
      • Mutations in the follicle-stimulating hormone (FSH) beta gene
      • Turner's syndrome (45 XO)
      • Galactosemia
    • Klinefelter's syndrome (47-XXY)
    • 46 XX primary ovarian deficiency:
      • Down's syndrome
      • Fragile-X permutation
      • 46 XX gonadal dysgenesis
      • Mutation of sex-determining region of Y chromosome (SRY) such as Swyer's syndrome
    • Cystic fibrosis
  • Congenital and acquired anatomical abnormalities:
    • Congenital absence of uterus and vagina
    • Imperforate hymen
    • Anorectal malformations
    • Transverse vaginal septum
    • Cervical atresia
    • Mullerian dysgenesis (MRKH syndrome)
    • Absolute uterine factors and other Mullerian anomalies
    • Asherman's syndrome
    • Endometriosis
    • Fibroids
    • Genital mutilation
    • Spina bifida or spinal injuries
    • Cerebral palsy
    • Bilateral cryptorchidism
    • Anorchia/Testicular regression
  • Receptor and enzyme defects:
    • Congenital adrenal hyperplasia (17 alpha-hydroxylase deficiency)
    • Androgen insensitivity syndrome due to defective androgen receptor
    • FSH, luteinizing hormone (LH) inactivating mutations leading to gonadotropin resistance
    • Aromatase deficiency
  • Growth and development problems:
    • Isolated gonadotropin-releasing hormone (GnRH) deficiency
    • Hypopituitarism
    • Constitutional delay of puberty
    • Congenital central nervous system defects
    • Age-related fecundity decline
  • Metabolic and endocrinological problems:
    • Polycystic ovary syndrome (PCOS)
    • Obesity
    • Congenital adrenal hyperplasia
    • 2Diabetes mellitus
    • Hypothyroidism and hyperthyroidism
    • Cushing's syndrome
    • Hypogonadotropic hypogonadism
    • Transgender
    • Pseudohypoparathyroidism
    • Hyperprolactinemia
    • Autoimmune ovarian insufficiency and premature ovarian failure
    • Empty sella and Sheehan's syndrome
    • Prader-Willi's syndrome and leptin deficiency
  • Neoplasia/tumors:
    • Craniopharyngioma
    • Pituitary adenoma
    • Ovarian tumors
    • Testicular tumors
    • Childhood cancer survivors of acute lymphoblastic leukemia, acute myeloid leukemia, non-Hodgkin lymphoma, neuroblastoma, soft tissue, and germ cell tumors
  • Infections:
    • Mumps
    • Chronic pelvic inflammatory diseases, e.g., chlamydia
    • Sexually transmitted infections (STIs)
    • Vulvovaginitis
    • Genital tuberculosis
    • Malaria
    • HIV/AIDS
    • Human papillomavirus (HPV) infection
    • Postpartum and postabortal sepsis (unsafe abortions)
  • Immunological and rheumatological:
    • Lupus/mixed connective tissue disease
    • Vasculitis
    • Steroid-dependent nephrotic syndrome
    • Rheumatoid arthritis
  • Other chronic ailments:
    • End-stage renal disease
    • End-stage liver disease
    • End-stage cardiac disease
    • End-stage lung disease
    • Dermatological conditions—anogenital warts, lichen planus, lichen sclerosis
  • Environmental and social:
    • Poor socioeconomic status
    • Genital trauma and mutilation
    • Poor perineal hygiene and menstrual hygiene
    • Use of local irritants, e.g., feminine sprays, soaps, perineal wash, etc.
    • Availability of clean toilets in schools and public places
    • Dietary factors—over nutrition and under nutrition
    • Use of tobacco and smoking
    • Excessive caffeine use, alcohol intake and drug abuse
    • Sexual abuse and violence
    • Exercise and extreme sports activities
    • Immunization status, e.g., HPV, etc.
    • Education level, gender bias, family, and partner support
    • Local cultural, religious, political factors
    • Legislation around age of marriage and employment
    • Environmental toxin exposer and endocrine disrupting chemicals (EDCs)
    • Preconception care and interventions
    • Accessibility and availability of adolescent reproductive and sexual health (ARSH) program and fertility preservation facilities
  • Mental and psychological state:
    • Psychological stress
    • Depression
    • Anxiety
    • High-risk behavior
    • Sexuality
    • Eating disorders
    • Dating violence
    • Poor mental health literacy and attending mental health services
  • Adolescent responsive quality healthcare:
    • ARSH program and sexual and reproductive health services
    • Poor treatment adherence—role of apps and other web-based technology
    • Fertility preservation services
    • Preconception counseling and care during pregnancy
    • Availability of HIV/AIDS, tuberculosis and STI treatment
    • Mental health services
    • School-based health services
    • Vaccination for measles, rubella, BCG, Hepatitis-B vaccine, diphtheria-tetanus, influenza, HPV, etc.
  • Iatrogenic:
    • Gonadotoxic chemotherapy: Alkylating agents, heavy metals
    • Gonadotoxic radiotherapy: Pelvic irradiation
    • Surgical extirpation of uterus and ovaries, Fallopian tubes for various indications
    • Orchidectomy.
 
3ASSESSMENT OF ADOLESCENTS FOR FUTURE FERTILITY
The parents of or chronically-ill adolescents may seek inquiry about scope of their future fertility. A systematic history, examination and investigations may be required for prognostication.13
 
History
A careful history taken in a very empathetic and confidential way is important which includes:
  • Detail childhood growth and development
  • Age at thelarche
  • Age at menarche
  • Any history of cyclical pelvic pain or prolonged pain in lower abdomen
  • Detailed menstrual history
  • Any history of amenorrhea
  • Dysmenorrhea or abnormal uterine bleeding
  • Past history of alcohol intake
  • Any drug intake for prolonged illness
  • History of any pelvic or perineal trauma, sexual abuse or violence
  • History of smoking or tobacco use or substance abuse
  • Sexual history, if relevant and contraceptive use and medical termination of pregnancy done in past
  • Any history of irradiation to pelvis in past
  • Any history of surgery done in pelvic area
  • Dietary history
  • History of any psychiatric illness or medication taken for same
  • History of excessive hair growth over body or face
  • History of galactorrhea, thyroid disease, pituitary or adrenal disease diabetes, tuberculosis, sexually transmitted diseases
  • Any history of hot flushes, anxiety, sleep disturbance, night sweats is to be elicited
  • Headache or visual field changes
  • Any history of bleeding disorder in the adolescent or family
  • History of genetic diseases and familial caners in the next of kin
  • History of HIV, AIDS, Hepatitis
  • Chronic kidney disease.
 
Examination
A thorough physical examination of adolescent is required which includes looking for:
  • Height
  • Weight
  • Body mass index (BMI)
  • Thyromegaly
  • Lymphadenopathy
  • Tanner staging and breast development
  • Systemic examination including respiratory, cardiovascular, neurological system
  • Vision and visual field
  • Blood pressure
  • Signs of virilization/hirsutism
  • Striac and pigmentation
  • Examination of inguinal canal for any palpable gonads
  • Urological and genital tract examination in both male and female adolescent
  • Testicular volume by Prader orchidometer
  • Evaluation in relevant cases for psychological age as against chronological age.
 
Investigations
These may be required both for diagnosis of underlying clinical conditions that affect fertility and their follow-up and prognostication of future fertility and reproductive outcomes.
  • Hemogram and platelet count
  • Erythrocyte sedimentation rate
  • Screening for diabetes
  • Thyroid function tests
  • S prolactin
  • FSH, LH, anti-Müllerian hormone (AMH), serum estradiol
  • S testosterone, dehydroepiandrosterone sulfate
  • Androstenedione, 17-OH progesterone
  • Coagulation profile and vonWillebrand disease panel
  • Kidney function test
  • Liver function test
  • Abdominal and pelvic ultrasound
  • Magnetic resonance imaging for pituitary and hypothalamus
  • Tests for bone age
  • Karyotype
  • Tumor marker in suspected malignancies, e.g., CA 125, alpha fetoprotein, beta hCG, carcinoembryonic antigen and lactate dehydrogenase, etc.
 
Counseling
It incorporates involvement of gynecologist, andrologist, geneticist, infertility/IVF specialist, and psychiatrist. Adolescents are made aware about their future fertility concerns along with parents initially 4and later in separate sessions as per requirement of confidentiality. Fertility awareness is generated in adolescents and their misconceptions and doubts are cleared regarding their reproductive and sexual health. This empowers adolescents to make informed reproductive choices and helps them to optimize their future fertility.7 A culture appropriate counseling is done to help parents overcome their emotional turmoil first so that they may help the adolescent later on in dealing with their self-esteem and body image issues in spite of their subfertility in certain conditions.
Adolescents are counseled about modifiable risk factors for infertility and are advised to make lifestyle modifications to conserve and preserve their future fertility and reproductive outcomes. They are given nutritional counseling and deficiencies are corrected. Adolescents are empowered to stop smoking, tobacco use, caffeine and alcohol intake in adequate number of counseling sessions. They are advised to optimize their BMI and moderate exercises are encouraged keeping into consideration their underlying clinical disease and exercise tolerance. Effort should be made to minimize their exposure to environmental toxins, EDCs and self-harming practices. The importance of good psychological assistance, support to allay stress and anxiety, and cognitive behavioral therapy, as and when required, cannot be underemphasized to maintain optimism for future fertility. Counseling about availability of fertility preservation options is important and is discussed ahead.9
Transgender adolescents pose challenges to counselors as their concern may depend on their parenthood desires, family perceptions about biological child, fertility information specific to them and finances involved in the process.8
 
MANAGEMENT OF SOME COMMON STEALERS OF FUTURE FERTILITY
 
Reproductive Tract Anomalies
Anomalies of female genital tract may be due to agenesis/hypoplasia, vertical fusion or canalization, and contact abnormalities with urogenital sinus, lateral fusion defects or resorption. Adolescents may present with amenorrhea, pain in lower abdomen or pelvis, unhealthy vaginal discharge or abnormal vaginal bleeding specially with obstructive anomalies. Adolescents into acute abdomen may be diagnosed with obstructive anomalies and need surgical intervention.
Many Mullerian anomalies remain undiagnosed during adolescence. They may present later on in life, when pregnancy is contemplated, with either recurrent pregnancy loss or infertility. Diagnosis of Mullerian agenesis may be a traumatizing experience to the adolescent or her family. Counseling by expert team is important as already mentioned and family should be informed about potential reproductive function due to normal ovarian function, including production of sex steroids and fertility options of assisted reproduction technologies and surrogacy is discussed. Creation of neovagina is delayed till adolescent is mature enough to understand nature of treatment and its timing. Most uterine fusion defects do not require surgical correction until there is specific concern of poor reproductive outcome in form of infertility or recurrent pregnancy loss. Absolute uterine factors may need surrogacy.
 
Sexually Transmitted Diseases
Adolescent females are more prone to develop sexually transmitted diseases than adult females and males. They may have asymptomatic infection and may not seek health care due to sociocultural barriers. This may have long-term reproductive implications, as may later on lead to pelvic inflammatory disease, which is an important cause of infertility and ectopic gestation. Timely diagnosis and treatment of STI such as Neisseria gonorrhoeae, chlamydia, trichomoniasis can prevent this. Young, sexually active adolescents may develop HPV infection. Persistence of high risk subtypes of HPV with oncogenic potential may lead to development of high grade cervical intraepithelial neoplasia and carcinoma cervix, if screening and timely intervention is not done HPV vaccination can prevent this dreadful consequence which may cause subfertility and may be fatal.
 
Abnormal Uterine Bleeding
Abnormal uterine bleeding due to varied causes, as discussed earlier, may give a hint to underlying pathology which may affect later fertility in adolescents. A careful evaluation needs to be done as per PALM-COEIN classification and cause specific treatment is instituted, as abnormal uterine bleeding may indicate irregular ovulation and dwindling fertility later on in life. Adolescents need correction of associated anemia for general health well-being and better reproductive outcomes later on in life.
 
Polycystic Ovary Syndrome and Other Conditions Associated with Hyperandrogenemia
Counseling of PCOS patients should be started early in adolescence regarding life style management to avoid development of metabolic syndrome later on in life. Metabolic syndrome can compromise fertility. PCOS 5itself causes infertility due to associated oligo-ovulation or anovulation. The association of unopposed estrogen exposure to development of endometrial hyperplasia and endometrial cancer later on in life may hamper fertility due to clinical condition itself or due to treatment given for the same, which may need medical or surgical interventions. Overzealous treatment of PCOS by ovarian drilling may itself cause decreased ovarian reserve, ovarian in-sufficiency and premature ovarian failure, so it must be avoided except in specific situations associated with infertility in late adolescence.
 
Endometriosis
Young adolescents may be diagnosed with this disease when their chronic pelvic pain does not respond to nonsteroidal anti-inflammatory drugs. Endometriosis in adolescents is usually associated with some obstructive Mullerian anomaly. As endometriosis is a progressive disease, patient may later on develop endometriomas and deep infiltrating endometriosis which may cause infertility due to decreased ovarian reserve, distortion of pelvic anatomy and disturbed tubo-ovarian relationship. Goal of therapy in young adolescents is symptomatic relief, suppression of disease progression, and protection of future fertility. Medical management with oral contraceptive pills, progestin therapy or GnRH agonist is preferred and surgery in adolescents is reserved only for patients who do not respond to medical management of chromic pelvic pain. As such, due to inherent progressive nature of disease, she may need multiple surgeries later on in life, may be as a part of infertility management. Patient can be put on continuous hormonal suppression till she is desirous of and contemplates pregnancy. Surgical treatment involves fulguration or complete excision of clear white vesicular and red lesions. Cystectomy, if needed, should involve complete cyst removal except near hilum to preserve ovarian reserve. Levonorgestrel-releasing intrauterine device (LNG-IUD) may be inserted at the time of laparoscopy to prevent recurrence of disease or patient may be given medical treatment as discussed before or etonogestrel subdermal implant may be given.14
 
Ovarian Cysts and their Torsion
Adolescents may present with simple or complex ovarian cysts. Conservative approach is desirable in form of simple observation or organ sparing surgery to protect their future fertility. Simple cysts less than 6 cm may be observed with or without giving combined oral contraceptive pills for around 3 months, to prevent recurrence. Cysts more than 10 cm will not regress usually and need laparoscopic intervention. Ovarian cysts may undergo torsion and may need conservative surgery in form of untwisting of ovarian pedicle and simple observation. Cystectomy at same sitting is avoided as it may lead to more traumas of friable ovarian tissues. The untwisted ovary usually regains its functions and looks normal on follow-up.15
Hemorrhagic cysts need observation and surgical treatment only in exceptional cases to protect fertility.
 
Adolescents with Cancer
Oncofertility is a developing science. Survivors of childhood cancers and newly diagnosed adolescents with hematological or genital malignancy will need comprehensive reproductive evaluation and follow-up regarding ensuing gonadal insufficiency, sexual dysfunction, and infertility. The disease itself or its management may cause disturbances in attainment of puberty which may be precocious or may get delayed.
As there is finite number of follicles in ovary, there may be age-related decline in fertility. Moreover, adolescents receiving alkylating agents such as cyclophosphamide and procarbazine or heavy metals as chemotherapeutic agents, have detrimental effect on their ovarian reserve in dose dependent and cumulative way. Prepubertal or pubertal gonadal irradiation may be a risk factor for hypogonadism. Older adolescents, due to their less number of oocyte stores, may develop acute ovarian failure (within 5 years of cancer treatment) or premature menopause or primary ovarian insufficiency. This causes sexual dysfunction due to vulvovaginal cicatrization or narrowing, dysfunction of ovary in form of dwindling hormonal function, and less lubrication and dryness caused by vestibular gland dysfunction.
It is prudent to discuss future fertility concerns at the start of cancer treatment to avoid any repentance later on. All “fertility preservation options” such as oocyte cryopreservation, ovarian cortex cryopreservation are discussed with adolescent and family. Option of embryo cryopreservation is offered if the adolescent has a partner. Some experimental studies are going on in vitro maturation of immature oocytes retrieved without any ovarian stimulation.
Ovarian transposition or oophoropexy before pelvic irradiation may be offered but future reproductive outcome is not ensured as uterus is not protected and may have irreversible endometrial and blood supply damage.
Studies are going on about use of GnRH agonist use during chemotherapy to quieten the ovary, as it will 6suppress ovarian function and decrease blood supply, minimizing the exposure of ovary to chemotherapeutic agents but results are not favoring it as standalone option. Menstrual lightening may be tried with combined hormonal contraceptives, LNG-IUD or depot medroxyprogesterone acetate injections. This will correct anemia of patient as well and provide contraception during cancer treatment as added advantage.
Male adolescents are offered sperm cryopreservation.
The follow-up assessment for fertility potential should continue closely during and after cancer treatment. The ethical and social issues of fertility cryopreservation must be discussed with parents and adolescents, as some adolescents later on in life may not be well enough to provide optimum parenting due to health issues and some may unfortunately not survive till embarking on conception.16-18
 
CONCLUSION
Most adolescents expect to have their biological children in future if properly counseled and given an option. The prognosis of fertility potential in future will depend upon underlying pathophysiology of their disease and effect of its treatment involved. The thieves and stealers of reproductive future of adolescents can only be conquered by timely diagnosis and management of the disease and therapy optimization. Fertility preservation option should be offered to adolescents diagnosed with cancer. Expert quality counseling regarding perception and priorities of adolescents about decision making for future fertility is the corner stone of treatment.
REFERENCES
  1. Rossi BV, Abusief M, Missmer SA. Modifiable risk factors and infertility: what are the connections? Am J Lifestyle Med. 2016;10(4):220–31.
  1. Sanfilippo JS, Lara-Torre E. Adolescent gynecology. Obstet Gynecol. 2009;113(4):935–47.
  1. Hertweck P, Yoost J. Common problems in pediatric and adolescent gynecology. Expert Review Obstet Gyne. 2010;5(3):311–28.
  1. DeSapri KAT, Lucidi RS. What are the differential diagnoses for Amenorrhea? [online] Available from: https://www.medscape.com/answers/252928-35725/what-are-the-differential-diagnoses-for-amenorrhea. [Last accessed November, 2019].
  1. Hallgarten A. Revolutionising reproduction: the future of fertility treatment. [online] Available from: https://www.bionews.org.uk/page-142170. [Last accessed November, 2019].
  1. Fertility factor (demography). [online] Available from: https://en.wikipedia.org/wiki/Fertility_factor_(demography). [Last accessed November, 2019].
  1. Kudesia R, Talib HJ. Fertility counseling for adolescents. Pediatric Annals. 2019;48(2):e86–91.
  1. Chen D, Kyweluk MA, Sajwani A, Gordon EJ, Johnson EK, Finlayson CA. Factors affecting fertility decision-making among transgender adolescents and young adults. LGBT Health. 2019;6(3):107–15.
  1. World Health Organization. Global Accelerated Action for the Health of Adolescents (AA-HA!): guidance to support country implementation coming of age adolescent health. Maternal, newborn, child & adolescent health. [online] Available from: https://www.who.int/maternal_child_adolescent/topics/adolescence/framework-accelerated-action/en/. [Last accessed November, 2019].
  1. Centers for Disease Control and Prevention. Common reproductive health concerns for women reproductive health. MedlinePlus.
  1. Mmari K, Blum RW. Risk and protective factors that affect adolescent reproductive health in developing countries: a structured literature review. Glob Public Health. 2009; 4(4):350–66.
  1. Adolescent sexual reproductive health. Child & adolescent health & development. World Health Organization website. 
  1. Gillam ML. Gynecologic problems of adolescence and puberty. [online] Available from: https://www.glowm.com/section_view/heading/Gynecologic%20Problems%20of%20Adolescence%20and%20Puberty/item/13. [Last accessed November, 2019].
  1. ACOG committee opinion. Dysmenorrhea and endometriosis in the adolescent. [online] Available from: https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Adolescent-Health-Care/Dysmenorrhea-and-Endometriosis-in-the-Adolescent?IsMobileSet=false. [Last accessed November, 2019].
  1. Murat OZ, Yakut HI, Ozgu BS, Ozgu E, Korkmaz E, Gungor T. Adolescent gynaecology: satisfying the needs for special patients. OA Women's Health. 2014;2(1):1.
  1. Levine JM. Preserving fertility in children and adolescents with cancer. Children (Basel). 2014;1(2):166–85.
  1. Peddie VL, Porter MA, Barbour R, Culligan D, MacDonald G, King D. Factors affecting decision making about fertility preservation after cancer diagnosis: a qualitative study. BJOG. 2012;119(9):1049–57.
  1. Gylynthia ET, Hoefgen Holly. Gynecologic issues in the pediatric and adolescent patient with cancer. Curr Treat Options Peds (2016) 2:196–208. Pediatric Gynecology (L Breechand K Stambough, section Editors). Published online: 19 July 2016. DOI 10.1.